David Hollander
Chief Tech/Sci/R&D Officer chez REVANCE THERAPEUTICS, INC.
Fortune : 535 557 $ au 31/03/2024
Profil
David A.
Hollander's current job(s) include serving as an Independent Director at Kiora Pharmaceuticals, Inc., as a Director at Arnold & Mabel Beckman Foundation, and as the Chief Medical Officer at Revance Therapeutics, Inc. Dr. Hollander's former job(s) include working as the VP & Head-Eye Care for Global Medical Affairs at Allergan, Inc., as the Chief Research & Development Officer at Aerie Pharmaceuticals, Inc., and.
as the Chief Medical Officer & Senior Vice President at Ora, Inc. Dr. Hollander's education history includes completing an undergraduate degree at Stanford University, earning an MBA from The Wharton School of the University of Pennsylvania, and obtaining a doctorate from the University of Pennsylvania Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/03/2024 | 108 853 ( 0,10% ) | 535 557 $ | 31/03/2024 | |
| 15/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de David Hollander
| Sociétés | Poste | Début |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director/Board Member | 13/12/2021 |
| REVANCE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/10/2022 |
Arnold & Mabel Beckman Foundation
 Arnold & Mabel Beckman Foundation Investment Trusts/Mutual FundsMiscellaneous Arnold & Mabel Beckman Foundation engages in the provision of support to young researchers. It focuses in the fields of chemistry and life sciences, broadly interpreted, and particularly to foster the invention of methods, instruments, and materials that open up new avenues of research and application in these sciences and related disciplines. It offers national programs and local community works. The company was founded by Arnold O. Beckman and Mabel Beckman in September 1977 and is headquartered in Irvine, CA. | Director/Board Member | - |
Anciens postes connus de David Hollander
| Sociétés | Poste | Fin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 28/02/2022 |
| ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | - |
Ora, Inc.
 Ora, Inc. Medical/Nursing ServicesHealth Services Ora, Inc. provides ophthalmic services. It engages in the provision of ophthalmic services and it specializes in allergy, allergic rhinitis, dry-eye, retina, anti-infective, anti-inflammatory, glaucoma, drug delivery, and ophthalmic devices. The firm offers development services including preclinical models, clinical research and development, regulatory strategy, statistics and data management, medical writing, and marketing and advertising. The company was founded by Mark Barry Abelson in 1985 and is headquartered in Andover, MA. | Chief Tech/Sci/R&D Officer | - |
Formation de David Hollander
| Stanford University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| University of Pennsylvania Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| REVANCE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Arnold & Mabel Beckman Foundation
Arnold & Mabel Beckman Foundation Investment Trusts/Mutual FundsMiscellaneous Arnold & Mabel Beckman Foundation engages in the provision of support to young researchers. It focuses in the fields of chemistry and life sciences, broadly interpreted, and particularly to foster the invention of methods, instruments, and materials that open up new avenues of research and application in these sciences and related disciplines. It offers national programs and local community works. The company was founded by Arnold O. Beckman and Mabel Beckman in September 1977 and is headquartered in Irvine, CA. | Miscellaneous |
Ora, Inc.
Ora, Inc. Medical/Nursing ServicesHealth Services Ora, Inc. provides ophthalmic services. It engages in the provision of ophthalmic services and it specializes in allergy, allergic rhinitis, dry-eye, retina, anti-infective, anti-inflammatory, glaucoma, drug delivery, and ophthalmic devices. The firm offers development services including preclinical models, clinical research and development, regulatory strategy, statistics and data management, medical writing, and marketing and advertising. The company was founded by Mark Barry Abelson in 1985 and is headquartered in Andover, MA. | Health Services |
